Paginas 7 y 8 .
Triple negative Tumors that are estrogen-receptor negative, HER2-negative, and progesterone-receptor negative .
Triple negativa tumores que son receptores de estrógenos negativos, HER2-negativos, y los receptores de progesterona negativos .
■ Trabectedin (Yondelis) Early research has shown that trabectedin is somewhat active against triple-negative breast cancers. The drug works by altering the genetic material in cancer cells, making it more difficult for them to thrive.